AwesomeAvani

VRPX Biotechnology Penny Stock Post Earnings

Pembelian
NASDAQ:VRPX   Virpax Pharmaceuticals, Inc.
VRPX was on a downtrend from mid-February into a reversal the beginning of May. VRPX

beat earnings up still has no cash flow which is very common in this subsector. VRPX is priced

on the potential of future earnings. The short and long-moving averages ratio shows bullish

momentum also shows strength with an upper Bollinger Band "walk". Price has climbed over

the POC line so it is higher than the mean of the share price traded for the duration of the

volume profile. I see this as a risky long setup expectant of a 40% profit based on the target

of the YTD high in February.
Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.